|
⚲
|
| Keyboard |
| Schlackman Scott
✚
|
|
|---|---|
| CIK # | 0001645617 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001645617] | |
| 4 | [0001645617] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Medifast Inc | |
| Schlackman Scott |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Medifast Inc MED
Common Stock
|
2025-06-25 | Grant | 11,168 | $0.00 | |
|
Medifast Inc MED
Common Stock
|
2024-06-20 | Grant | 6,596 | $0.00 | |
|
Medifast Inc MED
Common Stock
|
2024-03-08 | Option exercise | 1,300 | $27.68 | 35,984 |
|
Medifast Inc MED
Common Stock
|
2024-03-08 | Sell | 2,753 | $39.46 | 108,633 |
|
Medifast Inc MED
Common Stock
|
2024-03-08 | Sell | 1,300 | $39.41 | 51,233 |
|
Medifast Inc MED
Stock Option (Right to Buy) · derivative
|
2024-03-08 | Option exercise | 1,300 | $0.00 | |
|
Medifast Inc MED
Common Stock
|
2023-11-07 | Buy | 52.65 | $68.89 | 3,627 |
|
Medifast Inc MED
Common Stock
|
2023-08-08 | Buy | 39.82 | $89.42 | 3,561 |
|
Medifast Inc MED
Common Stock
|
2023-06-15 | Grant | 3,152 | $0.00 | |
|
Medifast Inc MED
Common Stock
|
2023-05-09 | Buy | 13.15 | $87.50 | 1,151 |
|
Medifast Inc MED
Stock Option (Right to Buy) · derivative
|
2023-03-10 | Option exercise | 2,200 | $0.00 | |
|
Medifast Inc MED
Common Stock
|
2023-03-10 | Sell | 2,200 | $108.68 | 239,096 |
|
Medifast Inc MED
Common Stock
|
2023-03-10 | Option exercise | 2,200 | $27.68 | 60,896 |
|
Medifast Inc MED
Common Stock
|
2023-02-07 | Buy | 9.80 | $114.97 | 1,127 |
|
Medifast Inc MED
Common Stock
|
2022-11-08 | Buy | 10.38 | $106.93 | 1,110 |
|
Medifast Inc MED
Common Stock
|
2022-08-08 | Grant | 7.91 | $138.78 | 1,098 |
|
Medifast Inc MED
Common Stock
|
2022-06-16 | Grant | 1,448 | $0.00 | |
|
Medifast Inc MED
Common Stock
|
2021-06-03 | Grant | 669 | $0.00 | |
|
Medifast Inc MED
Common Stock
|
2021-05-19 | Sell | 904 | $310.09 | 280,321 |
|
Medifast Inc MED
Common Stock
|
2021-05-19 | Sell | 96 | $311.57 | 29,911 |
| showing 20 of 37 most recent transactions | |||||